Tag Archives: LIMR

LIMR to host educational lecture on neuropathology indicators

Lankenau Institute for Medical Research (LIMR) invites all clinicians and researchers to join us for an educational lecture entitled “Brain endothelial-derived extracellular vesicles as indicators of neuropathology,” with Servio Ramirez, associate professor in the Department of Pathology and Laboratory Medicine … Continue reading

Posted in Clinician News | Tagged | Leave a comment

Clinical Trial of the Week: Device trial for patients diagnosed with left heart failure

By Donna Loyle, communications specialist, LIMR Patients diagnosed with significant heart failure and elevated left atrial pressure may qualify to participate in a prospective, early feasibility study that is examining the safety and efficacy of the Edwards transcatheter atrial shunt … Continue reading

Posted in Clinician News | Tagged | Leave a comment

Clinical Trial of the Week: Treatment trial for patients diagnosed with germline BRCA1/2 mutations and high-risk HER2 negative breast cancer

Researchers at Main Line Health are participating in a phase III study that is testing the safety and efficacy of olaparib (Lynparza®) vs. placebo in patients with germline BRCA1/2 mutations and high-risk HER2 negative breast cancer and who’ve completed local … Continue reading

Posted in Clinician News | Tagged | Leave a comment

Clinical Trial of the Week: Treatment trial for patients diagnosed with advanced rectal cancer

By Donna Loyle, communications specialist, LIMR Main Line Health is recruiting patients who’ve been diagnosed with locally advanced cancer of the rectum and in need of surgery. Researchers seek to determine overall survival and disease-free survival in patients administered a … Continue reading

Posted in Clinician News | Tagged , , | Leave a comment

Clinical Trial of the Week: Radiotherapy study for patients diagnosed with small cell lung cancer

By Donna Loyle, communications specialist, LIMR  Researchers are recruiting for a treatment trial for patients who have been diagnosed with small cell lung cancer that is confined to one hemithorax. All participants receive chemotherapy (either cisplatin or carboplatin) intravenously four … Continue reading

Posted in Clinician News | Tagged | Leave a comment

New approach to treat retinal diseases that cause blindness has been suggested by studies at Lankenau Institute for Medical Research

Investigators at the Lankenau Institute for Medical Research (LIMR), part of Main Line Health, showed that blocking the actions of a cellular protein called RhoB could limit diabetic retinopathy, macular degeneration and other diseases of the retina called retinopathies that … Continue reading

Posted in Clinician News | Tagged | Leave a comment

Clinical Trial of the Week: Treatment trial for patients with a certain type of colorectal cancer

By Donna Loyle, communications specialist, LIMR Researchers seek patients who’ve been diagnosed with locally advanced or metastatic HER2/Neu colorectal cancer and whose tumors cannot be surgically removed. Clinical study #S1613 is evaluating the efficacy of trastuzumab and pertuzumab (TP) in … Continue reading

Posted in Clinician News | Tagged | Leave a comment

Clinical Trial of the Week: Treatment trial for men with localized intermediate-risk prostate cancer

By Donna Loyle, communications specialist, LIMR Main Line Health researchers are conducting a treatment trial for men diagnosed with stage IIA-B prostate cancer. Study #NRG GU005 is a phase III clinical trial that seeks to determine the safety and efficacy … Continue reading

Posted in Clinician News | Tagged | Leave a comment

Clinical Trial of the Week: Device study for patients with severe mitral valve regurgitation

By Donna Loyle, communications specialist, LIMR The APOLLO clinical trial (#3809) is for patients who’ve been diagnosed with severe symptomatic mitral regurgitation and who’ve been told they need mitral valve replacement. This is a multi-center, global, prospective, interventional, pre-market trial … Continue reading

Posted in Clinician News | Tagged | Leave a comment

Clinical Trial of the Week: Study of financial burden in patients diagnosed with colorectal cancer

By Donna Loyle, communications specialist, LIMR Researchers seek patients who have been diagnosed with stage I-III colon or rectal cancer and who will undergo treatment. The study examines the financial burden of cancer care on patients. Collecting data from patients … Continue reading

Posted in Clinician News | Tagged | Leave a comment